MedPath

Physiotherapeutic treatment in chronic obstructive pulmonary disease (copd)

Not Applicable
Conditions
Chronic Obstructive Pulmonary Disease (COPD)
J44.9
Registration Number
RBR-4vgp58
Lead Sponsor
niversidade Federal da Paraíba
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruitment completed
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Volunteers with a proven diagnosis of COPD; not present neurological, cardiovascular and musculoskeletal problems; in addition to loss of cognitive ability, that made it impossible to carry out the evaluation and / or the treatment program.

Exclusion Criteria

Neurological, musculoskeletal, cardiovascular, problems; or loss of cognitive ability, making it impossible to perform the assessment and rehabilitation program proposed; not attend two consecutive treatment sessions.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement of ventilatory parameters, measured by spirometry (FEV1, Pi_max, Pe_max, CV and FVC), of the overall muscle strength measured by the palmar grip strength (dynamometry) and the electrical activity (EMG) of the accessory breathing muscles (sternocleidomastoid and anterior scalene) performed before and after 10 weeks of physiotherapeutic treatment.;Only, in relation to the manovacuometry (Pi_máx and Pe_máx), there was a significant increase in the values, both pre- and post-intervention, both in the Maneuvers group (Pi_max: P = 0.028; Pe_max: P = 0.046), as in the Threshold group (Pi_max: P = 0.028; Pe_max: P = 0.028).
Secondary Outcome Measures
NameTimeMethod
Improvement in the quality of life of patients with Chronic Obstructive Pulmonary Disease, observed through the Saint George Hospital Respiratory Disease Questionnaire (SGRQ).;In the comparison of SGRQ values, pre and post intervention, in the 3 domains and in the total score, there was a significant improvement for both the Maneuvers group (Symptoms: P = 0.003; Activities: P = 0.021; Psychosocial Impact: P = 0.018 and Total: P = 0.002), as well as for the Threshold group (Symptoms: P = 0.017; Activities: P = 0.012; Psychosocial Impact: P = 0.003 and Total: P = 0.001).
© Copyright 2025. All Rights Reserved by MedPath